Showing results (251-260 of 263) with videos related to
Sort By:
Pageof 27
European Journal of Epidemiology|September 1, 1993
Serum LP(A) levels in randomized healthy men from different European countriesM Cigolini, J C Seidell, M G Zenti, et al.Blood|January 15, 1991
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patientsS Siena, M Bregni, B Brando, et al.International Journal of Cancer|August 9, 2001
Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patientsM Spinola, T Nomoto, G Manenti, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2015
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerM Terenziani, M Massimino, D Magazzù, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II studyA Santoro, H Bredenfeld, L Devizzi, et al.Blood|July 27, 2000
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionM Magni, M Di Nicola, L Devizzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignanciesP Corradini, F Zallio, J Mariotti, et al.European Review for Medical and Pharmacological Sciences|October 20, 2022
Degenerative and inflammatory musculoskeletal disorders: updates and hot topics in diagnostic and interventional imagingR Monti, A Martinese, G Bonadonna, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trialG Bianchini, L Pusztai, T Pienkowski, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2022
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studyL Gianni, C S Huang, D Egle, et al.Pageof 27